International Clinical Trial: Study on the early predictive value of soluble growth stimulating expressed gene 2 protein and Endothelin-1 for the severity of hypertensive disorder complicating pregnancy

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119989) titled 'Study on the early predictive value of soluble growth stimulating expressed gene 2 protein and Endothelin-1 for the severity of hypertensive disorder complicating pregnancy' on March 6.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Huaibei Maternal and Child Health Care Hospital

Condition: hypertensive disorders of pregnancy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-01

Target Sample Size: study group:100;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=309620

Published by HT Dig...